Navigation Links
Coalition for 21st Century Medicine Endorses 'Patient Access to Critical Lab Tests Act'
Date:3/30/2009

- Legislation Seeks to Ensure Medicare Beneficiaries Have Access to Life-Saving Diagnostic Tests, Encourage Continued Innovation of Personalized Medicine -

WASHINGTON, March 30 /PRNewswire-USNewswire/ -- The Coalition for 21st Century Medicine today announced its full endorsement for the Patient Access to Critical Lab Tests Act, legislation introduced in the U.S. House of Representatives on March 25th by Representatives Jason Altmire (D-PA), Anna Eshoo (D-CA) and Tim Murphy (R-PA). The legislation will provide Medicare beneficiaries enhanced access to advanced diagnostic laboratory tests that can help improve the lives of millions of patients suffering from debilitating diseases. Additionally, the bill will encourage continued innovation in the burgeoning and promising field of personalized medicine.

Mapping the human genome has enabled revolutionary advances in understanding a wide variety of diseases and ushered in an era where treatments can be tailored to individual patients based on their DNA and the specific molecular character of their disease. Complex diagnostic laboratory tests make such "personalized medicine" possible. By understanding the molecular nature of disease, these new technologies increasingly allow clinicians and patients to pick individualized treatment options, rather than basing treatment choices on broad assessments of what works best for a population.

Current Medicare regulations thwart access to these important tests and discourage innovation by requiring hospitals to act as middlemen in the billing process. Laboratories are required to bill hospitals, and hospitals are required to bill Medicare. An access problem arises because hospitals are reluctant to assume the financial risk that the laboratory service will be covered and reimbursed by Medicare. The Patient Access to Critical Lab Tests Act would permit independent laboratories that develop and perform certain qualifying genetic, genomic or proteomic tests and cancer chemosensitivity assays to bill Medicare directly.

The Coalition for 21st Century Medicine applauds these Representatives for pursuing solutions to break down the barriers that block patients from receiving timely access to these important diagnostic tests.

About the Coalition for 21st Century Medicine

The Coalition for 21st Century Medicine represents some of the world's most innovative diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists and patient advocacy groups - all linked by a common mission to develop advanced diagnostics that improve the quality of healthcare for patients. For more information about the Coalition for 21st Century Medicine please visit http://www.twentyfirstcenturymedicine.org.


'/>"/>
SOURCE The Coalition for 21st Century Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Business, Labor, Academia and Bioscience Groups to Launch New Coalition to Promote Medical Innovation and Spark Economic Growth
2. Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes
3. Coalition to Protect Senior Care Applauds Senate Finance Health Subcommittee Hearing on Long Term Care Improvement as Part of Broad Health Care Reform
4. MARC Coalition Welcomes CMS Extension of MSP Reporting Requirements and Clarification of Reporting Thresholds
5. Broad Coalition Offers Plan to Improve Health Care Quality and Affordability
6. Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultzs The Early Act
7. Coalition to Protect Senior Care Urges House Ways and Means Panel to Reject MedPAC Recommendations on SNF Medicare Funding
8. MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition
9. Tony Coelho is Named New Chair of Coalition for Comparative Effectiveness Research
10. The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature
11. Food & Water Watch and International Coalition Members to Protest World Water Forum in Istanbul
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
(Date:1/13/2017)... ... ... The 18th European Congress: Perspectives in Lung Cancer will be held in ... is expertly designed to meet the educational needs of European oncology clinicians and researchers ... Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and organized ...
(Date:1/13/2017)... ... January 13, 2017 , ... An inventor from Virginia Beach, Va., is always ... order to diversify my outfits, so he decided to design something that enhances the ... the appearance of a belt to allow for quick, easy changing of its look. ...
(Date:1/13/2017)... , ... January 13, 2017 , ... MyGenetx, a molecular ... Communications, and Sales Administration Specialist, Mary Taylor Smith, RD, LD, will serve on the ... serving one year as a board member and one year as Vice President. She ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... 14, 2017  Johnson & Weaver, LLP announces that a ... Zimmer Biomet Holdings, Inc. (NYSE: ZBH )  securities ... 2016 (the "Class Period"). Zimmer Biomet provides musculoskeletal ... reconstructive products, such as knee and hip reconstructive products. ... According to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
Breaking Medicine Technology: